Monogram Technologies Inc

NASDAQ:MGRMUnited States

Depreciation and amortization 321,114 307,293 Change in fair value of warrant liability - (3,088,533) Changes in non-cash working capital balances: Account receivable 364,999 - Other current assets (168,691) 273,079 Accounts payable (925,605) 1,121,822 Accrued liabilities 490,504 (197,243) Operating lease assets and liabilities, net 825 5,622 ----------- ----------- Cash used in operating activities (10,967,238) (10,430,384) Investing activities: Purchases of equipment (47,809) (40,765) ----------- ----------- Cash used in investing activities (47,809) (40,765) Financing activities: Proceeds from issuances of Common Stock, net of cash costs 4,177,931 15,254,300 ELOC issuance cost - (523,362) Proceeds from issuances of Series C Preferred Stock, net - 147,042 Proceeds from issuances of Series D Preferred Stock, net 9,813,230 - ----------- ----------- Cash provided by financing activities 13,991,161 14,877,980 ----------- ----------- Increase (decrease) in cash and cash equivalents during the period 2,976,114 4,406,831 Cash and cash equivalents, beginning of the period 13,589,028 10,468,645 ----------- ----------- Cash and cash equivalents, end of the period $ 16,565,142 $ 14,875,476 =========== =========== Noncash investing and financing activities: Receivable from stock offerings' selling agent $ 1,378,867 $ - Amortization of deferred issuance costs of Common Stock Purchase Agreement $ 145,956 $ - Series D Preferred Stock dividends payable $ 120,860 $ - Cashless exercise of warrant $ 246 $ 926,335 Common Stock issued for services related to Common Stock Purchase Agreement $ - $ 247,980

AUSTIN, TX / ACCESSWIRE / November 12, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, will hold a conference call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time in conjunction with its reported financial results for the third quarter ended September 30, 2024 and to discuss key milestones. A press release detailing these results will be issued prior to the call.